Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses. The Company's aim is to bring innovative medicines to China in order to improve public health.
|Employees (est.) (Sept 2020)||48||(+3%)|
Brii Biosciences total Funding
Brii Biosciences latest funding size
Time since last funding
|2 years ago|
Brii Biosciences investors
|Boyu Capital, ARCH Venture Partners, Blue Pool Capital, YF Capital (Yunfeng Capital), 6 Dimensions Capital, Sequoia Capital China|
When was Brii Biosciences founded?
Brii Biosciences was founded in 2018.
Who are Brii Biosciences key executives?
Brii Biosciences's key executives are Zhi Hong, Li Yan and Lianhong Xu.
How many employees does Brii Biosciences have?
Brii Biosciences has 48 employees.
Who are Brii Biosciences competitors?
Competitors of Brii Biosciences include BioSpecifics Technologies, NeuroVive Pharmaceutical and Acousia Therapeutics.
Where are Brii Biosciences offices?
Brii Biosciences has offices in Beijing, Durham, San Francisco and San Mateo.
How many offices does Brii Biosciences have?
Brii Biosciences has 5 offices.
Receive alerts for 300+ data fields across thousands of companies